Mosaic Therapeutics secures $28m funding and appoints CEO
Oncology therapeutics company Mosaic Therapeutics has announced the close of its $28 million series A funding round. The company has also appointed former Novartis Oncology SVP Brian Gladsden as CEO.
First NHS Trust to adopt Aiforia’s lung cancer model in clinical diagnostics
The first NHS Trust of the PathLAKE Plus consortium has signed an individual contract to adopt Aiforia PD-L1 AI model for lung cancer in clinical diagnostics. The duration of the contract is three years, with a possible three-year extension.
Capitainer launches fully automated sample handler
Capitainer has launched a fully automated sample handler that enables large-scale screening and diagnostics using the company’s self-sampling products. This technology effectively cuts down on the number of manual steps and reduces the time that laboratory staff spend preparing Capitainer samples for analysis.
MUJN Diagnostics links with Hemex Health for brain therapies
MUJN Diagnostics – a subsidiary of PanGenomic Health – is partnering with Portland, Oregon-based medical diagnostic device company Hemex Health to develop a diagnostics system, which can be used to support patients being treated with alternative therapies for brain health.
Congress: an opportunity for all biomedical scientists
The IBMS Congress continues to provide as many options to attend its highly popular programmes as it is possible to cram into a comprehensive four-day programme.
Collaboration to explore the feasibility of a device that supports non-melanoma skin cancer detection
PHC and NovaScan have announced the launch of a collaboration through which they will seek to explore the feasibility of MarginScan, an investigational ex vivo medical device that will seek to support clinicians in detecting non-melanoma skin cancers (NMSC).
All-in-one solution for widefield and spinning disk confocal microscopy
CrestOptics, a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, has announced the launch of CICERO, its new spinning disk confocal microscope system. Focusing on the essential elements of epifluorescence and confocal microscopy, CICERO has been developed to make high-end imaging accessible to the wider scientific community by providing a compact and cost-effective system for powerful imaging solutions.
Next epidemic could be spotted early in wastewater
Routine monitoring at sewage treatment works could provide a powerful early warning system for the next influenza or norovirus epidemic.
Annual BSMT Microbiology Conference: book before 10 April for discounted rates
Register now for the British Society for Microbial Technology (BSMT) 38th Annual Microbiology Conference, as early bird booking rates are only available until 10 April.
Lunaphore expands COMET spatial biology solution portfolio
Lunaphore, a Swiss life-sciences company developing technology to enable spatial biology in every laboratory, has expanded its COMET platform and product suite, which now includes a wide range of tools and applications across all research and drug development stages.
NHS consulting on sharing private healthcare data
A consultation is open on recommendations that NHS England should collect and process information on healthcare activity carried out at private hospitals. Plans to create a single source of healthcare data in England to improve the quality of care for patients are the focus of a consultation which is part of the Acute Data Alignment Programme (ADAPt).
BSMT Annual Microbiology Conference – time to register
Register now for the British Society for Microbial Technology (BSMT) 38th Annual Microbiology Conference, as early bird booking rates are available until 10 April.
Olink Proteomics available in the UK via Source Genomics
Source Genomics is the first UK-based commercial service provider of Olink Proteomics. The company has partnered with Olink to maximise the power of proteomics, providing high-throughput and scalable biomarker discovery for laboratory projects with unparalleled specificity.
Fujirebio expands neurodegenerative diseases assay menu
Fujirebio has announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE G immunoassay systems.
Thermo Fisher Scientific opens cell therapy facility at University of California
Thermo Fisher Scientific and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus.
Government sets out strategy to protect NHS from cyber attacks
The government has published a new plan to promote cyber resilience across the health and care sectors by 2030, protecting both services and patients.
Boots to pilot diabetes screening with the LumiraDx HbA1c test
National pharmacy retail chain Boots has announced a UK-wide diabetes screening pilot which will offer a private screening service to customers using the LumiraDx platform and HbA1c test.
Bio-Rad launches new thermal cyclers
Bio-Rad Laboratories has launched the new PTC Tempo 96 and PTC Tempo Deepwell thermal cyclers, designed to optimise PCR applications such as sequencing, cloning, and genotyping.
Proxim Diagnostics announces bioMérieux investment
Proxim Diagnostics, a company developing a handheld, point-of care diagnostic device, announced it has received a strategic investment from bioMérieux, a world leader in the field of in vitro diagnostics.
MHRA to streamline clinical trial approvals
A series of new measures will be introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) with support from partners to make it faster and easier to gain approval and to run clinical trials in the UK.
CellPath Limited is a UK-based independent company, specialising in the manufacture and worldwide supply of products, consumables and services to the Cellular Pathology sector.
With an in-house state of the art injection moulding capability, we differentiate ourselves in the marketplace through being able to directly manufacture many of the...
Royal Armouries, Leeds
12-14 June 2023
Liverpool Pathology 2023
University of Liverpool
Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)
Manchester Central Conference Centre
4-6 July 2023
Annual SHOT Symposium 2023
Etihad Stadium, Manchester, M11 3FF
4 July 2023
SHOT webinar: Positive patient identification for safe transfusions in adults
SHOT webinar: Accurate and complete patient identification for safe transfusions in children
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store